IART — Integra LifeSciences Holdings Share News
0.000.00%
Last trade - 00:00- $1.05bn
- $2.65bn
- $1.64bn
Organogenesis hits 9-month high over BTIG rating upgrade
U.S. STOCKS ON THE MOVE-Citigroup, Tigo Energy, Children's Place
U.S. STOCKS ON THE MOVE-Shoe Carnival, Intuit, Abercrombie & Fitch
JPM, Citi downgrade Integra LifeSciences on Q2 outlook cut after product recall
U.S. RESEARCH ROUNDUP-Empire State, Integra Lifesciences, Lowe's Companies
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma
Integra LifeSciences falls on cutting Q2 outlook after voluntary product recall
U.S. STOCKS ON THE MOVE-Yelp, Shutterstock, TCS
Integra LifeSciences cuts Q2 forecast on voluntary product recall; shares down
Brief: Integra Lifesciences Initiated Voluntary Global Recall Of All Products Made In Boston Facility Distributed Between March 1, 2018 And May 22
Integra LifeSciences slip on lower-than-expected Q2 forecasts
Integra Lifesciences Holdings Corp reports results for the quarter ended in March - Earnings Summary
Brief: Integra Lifesciences Reports First Quarter 2023 Financial Results
Brief: Integra Lifesciences Q1 EPS USD 0.29
Integra Lifesciences Holdings Corp expected to post earnings of 74 cents a share - Earnings Preview
Brief: Integra Lifesciences Holdings Corp - On March 24, Entered Into Amended And Restated Credit Agreement That Makes Up To $2.075 Billion Available To Co
U.S. RESEARCH ROUNDUP-Cinemark Holdings, Commercial Metals Co, Nvidia
Integra Lifesciences Holdings Corp reports results for the quarter ended in December - Earnings Summary